AI on the Hill

This is an excerpt from Crashing Excel to Curing Cancer — How AI and Open Science Are Rewiring Drug Discovery(Part 1/6).

In this episode, host René Bastón, Venture Partner at Covenant Venture Capital, sits down with Tommy Tang, Director of Bioinformatics at AstraZeneca.

Tommy talks about the culture shock he experienced as an international student, his shift from wet-lab research to computational biology, and how he self-taught pro...

This is an excerpt from Crashing Excel to Curing Cancer — How AI and Open Science Are Rewiring Drug Discovery(Part 2/6).

In this episode, host René Bastón, Venture Partner at Covenant Venture Capital, sits down with Tommy Tang, Director of Bioinformatics at AstraZeneca.

Tommy’s career took a pivotal turn when a massive dataset overwhelmed his Excel, sparking his self-driven journey into data science. Lacking external support, he ta...

This is an excerpt from Crashing Excel to Curing Cancer — How AI and Open Science Are Rewiring Drug Discovery(Part 3/6).

In this episode, host René Bastón, Venture Partner at Covenant Venture Capital, sits down with Tommy Tang, Director of Bioinformatics at AstraZeneca.

Tommy’s career took a pivotal turn when a massive dataset overwhelmed his Excel, sparking his self-driven journey into data science. Lacking external support, he ta...

This is an excerpt from Crashing Excel to Curing Cancer — How AI and Open Science Are Rewiring Drug Discovery(Part 4/6).

In this episode, host René Bastón, Venture Partner at Covenant Venture Capital, sits down with Tommy Tang, Director of Bioinformatics at AstraZeneca.

AI, bioinformatics, and computational biology are reshaping how cancer drugs are discovered and developed. Tommy explains how data-driven insights—from target ident...

This is an excerpt from Crashing Excel to Curing Cancer — How AI and Open Science Are Rewiring Drug Discovery(Part 5/6).

In this episode, host René Bastón, Venture Partner at Covenant Venture Capital, sits down with Tommy Tang, Director of Bioinformatics at AstraZeneca.

Large language models and machine learning promise to revolutionize drug development—but what does it take to make that real? In this episode, we explore the critic...

This is an excerpt from Crashing Excel to Curing Cancer — How AI and Open Science Are Rewiring Drug Discovery(Part 6/6).

In this episode, host René Bastón, Venture Partner at Covenant Venture Capital, sits down with Tommy Tang, Director of Bioinformatics at AstraZeneca.

Open science isn’t just a philosophy—it’s a catalyst for progress. In this episode, we explore how sharing code, data, and methods empowers researchers, accelerates...

Welcome to AI on the Hill, the podcast where we explore the intersection of artificial intelligence and biotechnology, featuring thought leaders and innovators who are shaping the future of drug development and health tech. In this series, host René Bastón, Venture Partner at Covenant Venture Capital, and expert guests like Dean Zheng, Clinical Outsourcing Professional at Pfizer, discuss how AI is streamlining clinical trial operat...

This is an excerpt from From Wall Street Beats to Biotech Breakthroughs — Dean’s journey from DJ booths and banking to leading AI-driven clinical trial innovations (Part 1/6).

In this episode, host René Bastón, Venture Partner at Covenant Venture Capital, sits down with Dean Zheng, Clinical Outsourcing Professional at Pfizer.

Dean shares his unconventional career path — starting as a DJ and music producer, moving into investment ba...

This is an excerpt from From Wall Street Beats to Biotech Breakthroughs — Dean’s journey from DJ booths and banking to leading AI-driven clinical trial innovations (Part 2/6).

In this episode, host René Bastón, Venture Partner at Covenant Venture Capital, continues the conversation with Dean Zheng, Clinical Outsourcing Professional at Pfizer.

Dean reflects on his transitions between three distinct worlds — investment banking, contr...

This is an excerpt from From Wall Street Beats to Biotech Breakthroughs — Dean’s journey from DJ booths and banking to leading AI-driven clinical trial innovations (Part 3/6).

In this episode, host René Bastón, Venture Partner at Covenant Venture Capital, talks with Dean Zheng, Clinical Outsourcing Professional at Pfizer, about the real-world impact of AI in pharma operations.

Dean shares how tools like ChatGPT-based copilots are t...

This is an excerpt from From Wall Street Beats to Biotech Breakthroughs — Dean’s journey from DJ booths and banking to leading AI-driven clinical trial innovations (Part 4/6).

In this episode, host René Bastón, Venture Partner at Covenant Venture Capital, and Dean Zheng, Clinical Outsourcing Professional at Pfizer, dive into how AI is transforming the clinical trial process—especially in biostatistics and data management.

Dean expl...

This is an excerpt from From Wall Street Beats to Biotech Breakthroughs — Dean’s journey from DJ booths and banking to leading AI-driven clinical trial innovations (Part 5/6).

In this episode, host René Bastón, Venture Partner at Covenant Venture Capital, explores with Dean Zheng, Clinical Outsourcing Professional at Pfizer, how pharma companies are rethinking their relationships with vendors.

Dean breaks down the pros and cons of ...

This is an excerpt from From Wall Street Beats to Biotech Breakthroughs — Dean’s journey from DJ booths and banking to leading AI-driven clinical trial innovations (Part 6/6).

In this final episode, host René Bastón, Venture Partner at Covenant Venture Capital, wraps up the conversation with Dean Zheng, Clinical Outsourcing Professional at Pfizer, by exploring the career and life lessons Dean has learned along the way.

Dean reflect...